Back
EndLyz

EndLyz

EndLyz is an early stage biotech company developing disease-modifying therapeutics that restore endo-lysomsomal function to treat neurodegenerative disorders such as Parkinson’s Disease and other dementias.

What
Life Sciences
When
Jul 2021
CEO
Joanna Wolak
Status
Private
Investment
Active
OSE Board Director
Craig Fox